SIRT4 and SIRT5 exhibit tumor-suppressive roles in hepatocellular carcinoma, impacting SET domain-containing protein 8 and acyl-CoA oxidase 1, respectively (Chen et al., 2019, Chen et al., 2018). Here, SIRT4 is linked to neoplasm.